FXAIX
Price
$183.49
Change
+$0.25 (+0.14%)
Updated
Apr 17 closing price
Net Assets
597.55B
JENSX
Price
$54.05
Change
-$0.66 (-1.21%)
Updated
Apr 17 closing price
Net Assets
5.85B
Ad is loading...

FXAIX vs JENSX

Header iconFXAIX vs JENSX Comparison
Open Charts FXAIX vs JENSXBanner chart's image
Fidelity 500 Index
Price$183.49
Change+$0.25 (+0.14%)
VolumeN/A
Net Assets597.55B
Jensen Quality Growth J
Price$54.05
Change-$0.66 (-1.21%)
VolumeN/A
Net Assets5.85B
FXAIX vs JENSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FXAIX vs. JENSX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and JENSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 598B vs. JENSX (5.85B). FXAIX pays higher dividends than JENSX: FXAIX (1.30) vs JENSX (0.48). FXAIX was incepted earlier than JENSX: FXAIX (14 years) vs JENSX (33 years). JENSX (0.81) is less costly to investors than FXAIX (0.01). JENSX is a more actively managed with annual turnover of: 10.46 vs. FXAIX (2.00). FXAIX has a lower initial minimum investment than JENSX: FXAIX (0) vs JENSX (2500). FXAIX annual gain was more profitable for investors over the last year : 6.45 vs. JENSX (-6.67). FXAIX return over 5 years is better than : 98.09 vs. JENSX (18.80).
FXAIXJENSXFXAIX / JENSX
Total Expense Ratio0.010.812%
Annual Report Gross Expense Ratio0.010.812%
Fund Existence14 years33 years-
Gain YTD-9.974-5.977167%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets598B5.85B10,226%
Annual Yield % from dividends1.300.48274%
Returns for 1 year6.45-6.67-97%
Returns for 3 years25.76-7.96-324%
Returns for 5 years98.0918.80522%
Returns for 10 years174.8643.01407%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSGRX60.610.27
+0.45%
Putnam Small Cap Growth R
DRLAX8.14N/A
N/A
BNY Mellon Developed Markets RE Scs - A
ICTEX13.37N/A
N/A
ICON Health and Information Tech Instl
HGHFX36.75N/A
N/A
Hartford Healthcare F
ALCKX85.57N/A
N/A
AB Large Cap Growth K